In a well-documented cohort of patients selected on the basis of anti-U1-snRNP positivity, we found that 27% were diagnosed with MCTD, 54% with SLE and other clinical conditions as reported in the literature [2,17]. This evidence concerns the gene LSM2 and mixed connective tissue disease.